US Stock MarketDetailed Quotes
GILD Gilead Sciences
- 88.820
- +0.530+0.60%
Close Oct 31 16:00 ET
- 88.170
- -0.650-0.73%
Post 19:06 ET
110.58BMarket Cap108.32P/E (TTM)
89.280High87.740Low5.89MVolume87.940Open88.290Pre Close523.72MTurnover0.47%Turnover Ratio19.74P/E (Static)1.24BShares89.74052wk High6.05P/B110.37BFloat Cap60.75052wk Low3.04Dividend TTM1.24BShs Float89.740Historical High3.42%Div YieldTTM1.74%Amplitude0.405Historical Low88.848Avg Price1Lot Size
About Gilead Sciences Company
Gilead Sciences, Inc. is a biopharmaceutical company, which engages in the research, development, and commercialization of medicines in areas of unmet medical need. The firm's primary areas of focus include human immunodeficiency virus, acquired immunodeficiency syndrome, liver diseases, hematology, oncology, and inflammation and respiratory diseases. It offers antiviral products under Harvoni, Genvoya, Epclusa, Truvada, Atripla, Descovy, Stribild, Viread, Odefsey, Complera/Eviplera, Sovaldi, and Vosevi brands. The company was founded by Michael L. Riordan on June 22, 1987 and is headquartered in Foster City, CA.
Company Profile
SymbolGILD
Company NameGilead Sciences
Listing DateJan 22, 1992
Issue Price15.00
Founded1987
CEOMr. Daniel P. O'Day
MarketNASDAQ
Employees18000
Fiscal Year Ends12-31
Address333 Lakeside Drive
CityFoster City
ProvinceCalifornia
CountryUnited States of America
Zip Code94404
Phone1-650-574-3000
Websitehttp://www.gilead.com
Company Executives
- Name
- Position
- Salary
- Daniel P. O'Day
- Chairman of the Board and Chief Executive Officer
- 22.61M
- Daniel O’Day
- Chairman of the Board and Chief Executive Officer
- --
- Sandra Patterson
- Senior Vice President, Assistant Controller and Chief Accounting Officer
- --
- Johanna Mercier
- Chief Commercial Officer
- 8.59M
- Dr. Merdad V. Parsey, M.D.,PhD
- Chief Medical Officer
- 8.39M
- Andrew D. Dickinson
- Chief Financial Officer
- 8.11M
- Deborah H. Telman
- Executive Vice President, Corporate Affairs, Corporate Secretary and General Counsel
- 5.27M
- Dr. Ted W. Love, M.D.
- Director
- --
- Harish Manwani
- Independent Director
- 414.92K
- Dr. Sandra J. Horning, M.D.
- Independent Director
- 429.92K
- Jeffrey A. Bluestone
- Independent Director
- 409.92K
- Javier J. Rodriguez
- Independent Director
- 399.92K
- Dr. Jacqueline K. Barton, PhD
- Independent Director
- 429.92K
- Kelly Anne Kramer
- Independent Director
- 434.92K
- Anthony Welters
- Independent Director
- 444.92K
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data
